Displaying 1121 - 1140 of 1570
Concurring Statement of Commissioner J. Thomas Rosch on the Release of the 2010 Horizontal Merger Guidelines
Federal Trade Commission and U.S. Department of Justice Issue Revised Horizontal Merger Guidelines
Carilion Clinic, a corporation, In the Matter of
The Commission issued an administrative complaint challenging Carilion Clinic’s 2008 acquisition of two competing outpatient clinics in the Roanoke, Virginia, area. The complaint alleges that Carilion’s acquisition of these outpatient centers eliminated competition for patients in the Roanoke area. On October 7, 2009 Carillion agreed to sell two independent outpatient medical clinics it acquired last year to settle the charges.
FTC Order Restores Competition in U.S. Markets for Herbicide Products
Solvay S.A
Solvay settled antitrust concerns stemming from its proposed acquisition of Ausimont S.p.A. from Italenergia S.p.A., and agreed to divest its U.S. polyvinylidene fluoride (PVDF) operations and its interest in Alventia LLC, a joint venture which manufactures the main raw material for PVDF. According to the complaint, the proposed acquisition would lessen competition in two markets: the production and sale of all grades of PVDF; and the production and sale of melt-processible grades of PVDF.
Fidelity National Financial Settles FTC Charges that its Acquisition of LandAmerica Subsidiaries Reduced Competition in Title Information Markets
FTC Requires Conditions for Pilot Corporation's Takeover of Flying J Inc.'s Travel Center Business
FTC Approves Final Settlement Regarding Agilent Technologies' Proposed Acquisition of Varian
Service Corporation International and Keystone North America Inc., In the Matter of
Service Corporation International (SCI), the nation’s largest provider of funeral and cemetery services, settled Commission charges that its proposed acquisition of Keystone North America Inc., the fifth-largest funeral and cemetery services provider in North America, raises antitrust concerns in several local markets for funeral services and cemetery services. The order requires SCI to sell 22 funeral homes and four cemeteries in 19 local markets to ensure competition is preserved following its acquisition of Keystone.
FTC Order Preserves Competition Threatened by Agilent's Acquisition of Varian
FTC Challenges Dun & Bradstreet's Purchase of Competing Education Data Provider
FTC Order Preserves Competition That Would Have Been Eliminated by SCI's Acquisition of Keystone North America Inc.
Danaher Corporation and MDS, Inc., In the Matter of
The Commission challenged Danaher’s proposed acquisition of MDS Analytical Technologies, requiring that MDS divest its assets related to its laser microdissection business. The proposed settlement is designed to preserve competition in the North American market for laser microdissection devices – a key tool for scientific research.
Administrative Law Judge Rules That Polypore International's 2008 Acquisition of Rival Battery Separator Manufacturer Violated Antitrust Law
Service Corporation International, In the Matter of
The Commission challenged Service Corporation International's (SCI) proposed acquisition of local rival Palm Mortuary, Inc. At the time of the acquisition, SCI, the nation’s largest cemetery operator, was the third-largest provider of cemetery services in Las Vegas, Nevada, and after the acquisition of Palm, would have controlled 76 percent of hte market for funeral services, which includes burial plots, opening and closing of graves, memorials, burial vaults, mausoleum spaces, and cemetery maintenance. The Commission's order required SCI to sell its cemetery and funeral home in Las Vegas to complete the acquisition of Palm.
Horizontal Merger Guidelines Review Project
Watson Pharmaceuticals, Inc., a corporation, and Robin Hood Holdings Limited, a limited liability company, In the Matter of
The Commission charged that Watson Pharmaceuticals, Inc.’s acquisition of Robin Hood Holdings Limited, owner of Arrow Pharmaceuticals, would have harmed consumers by eliminating future competition for important generic drugs used to treat Parkinson’s disease (cabergoline) and the side effects of chemotherapy (dronabinol). The Commission’s order requires the firms to sell assets related to the two drugs to FTC-approved buyers and to ensure the acquirers have the means to compete effectively in the future.
There is a related federal proceeding and two related administrative proceedings:
Horizontal Merger Guidelines Review Project
FTC's Closure of Its Investigation of Consummated Hospital Merger in Temple, Texas
Displaying 1121 - 1140 of 1570